Polymer selection in amorphous solid dispersions: From stabilization mechanisms to marketed drug products
Journal of Controlled Release · 2026-07 · 395 · 115014
DOI: 10.1016/j.jconrel.2026.115014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-07. Verfasst von Abdulrahman Alzyoud und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; Research Instit…. Hauptthemen laut MEDLINE: Bulk Drugs, Polymers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 266 Literaturangaben. Gefördert von: University of Sharjah.
Abstract (Originalsprache)
Polymers are a central component of amorphous solid dispersions (ASDs), playing a crucial role in maintaining the drug in a high-energy amorphous state. They ensure both physical and chemical stability, inhibit drug crystallization, and sustain supersaturation during dissolution, thereby enabling ASDs to enhance drug dissolution and bioavailability. While ASDs have been extensively studied, the specific role of polymers in governing supersaturation and in vivo performance remains insufficiently addressed. In this review, the fundamental principles governing the selection and performance of polymers in ASD formulations were explored. The classification, molecular interactions, and mechanisms of stabilization were reviewed. Key aspects of polymer physicochemical properties, scalability considerations, and regulatory perspectives are also discussed. Factors influencing the success of ASD products in clinical and commercial settings were also considered. Finally, the review presents an overview of marketed ASD-based formulations and outlines emerging trends in polymer innovation aimed at improving drug solubility and manufacturability. The review concludes that optimal polymer selection is a critical determinant of ASD performance, as it governs both resistance to crystallization and maintenance of supersaturation during dissolution. It highlights the limitations of conventional polymer selection strategies and emphasizes the need for a paradigm shift toward solution-phase stabilization as a primary design criterion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, Un…
- Global Product Development, AstraZeneca, Gothenburg, Sweden.
Förderung
- University of Sharjah
Zitieren
APA
Alzyoud, A., El Sayed, M., Rawas-Qalaji, M., & Alhalaweh, A. (2026). Polymer selection in amorphous solid dispersions: From stabilization mechanisms to marketed drug products. Journal of Controlled Release, 395, 115014. https://doi.org/10.1016/j.jconrel.2026.115014
Vancouver
Alzyoud A, El Sayed M, Rawas-Qalaji M, Alhalaweh A. Polymer selection in amorphous solid dispersions: From stabilization mechanisms to marketed drug products. Journal of Controlled Release. 2026;395:115014. doi:10.1016/j.jconrel.2026.115014
BibTeX
@article{Alzyoud2026,
author = {Alzyoud, Abdulrahman and El Sayed, Mira and Rawas-Qalaji, Mutasem and Alhalaweh, Amjad},
title = {Polymer selection in amorphous solid dispersions: From stabilization mechanisms to marketed drug products},
journal = {Journal of Controlled Release},
year = {2026},
volume = {395},
pages = {115014},
doi = {10.1016/j.jconrel.2026.115014}
}
EUVIMED